LLY

1,154.99

+1.59%↑

JNJ

239.45

+0.21%↑

ABBV

225.16

-0.5%↓

UNH

405.7

-0.03%↓

MRK

121.51

+3.05%↑

LLY

1,154.99

+1.59%↑

JNJ

239.45

+0.21%↑

ABBV

225.16

-0.5%↓

UNH

405.7

-0.03%↓

MRK

121.51

+3.05%↑

LLY

1,154.99

+1.59%↑

JNJ

239.45

+0.21%↑

ABBV

225.16

-0.5%↓

UNH

405.7

-0.03%↓

MRK

121.51

+3.05%↑

LLY

1,154.99

+1.59%↑

JNJ

239.45

+0.21%↑

ABBV

225.16

-0.5%↓

UNH

405.7

-0.03%↓

MRK

121.51

+3.05%↑

LLY

1,154.99

+1.59%↑

JNJ

239.45

+0.21%↑

ABBV

225.16

-0.5%↓

UNH

405.7

-0.03%↓

MRK

121.51

+3.05%↑

Search

Illumina Inc

Open

BrancheGesundheitswesen

162.18 -0.25

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

160.26

Max

165.42

Schlüsselkennzahlen

By Trading Economics

Einkommen

-200M

134M

Verkäufe

-68M

1.1B

KGV

Branchendurchschnitt

28.735

49.052

EPS

1.15

Gewinnspanne

12.282

Angestellte

8,600

EBITDA

-144M

301M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

-9.37% downside

Dividenden

By Acuity

Nächstes Ergebnis

30. Juli 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

4.4B

24B

Vorheriger Eröffnungskurs

162.43

Vorheriger Schlusskurs

162.18

Nachrichtenstimmung

By Acuity

52%

48%

262 / 344 Ranking in Healthcare

Illumina Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

10. Juni 2026, 23:11 UTC

Illumina Inc shares are higher in after-market trading, supported by a notable upward trend in the Life Sciences Tools & Services sub-sector.

9. Juni 2026, 19:26 UTC

News

Illumina shares are advancing, supported by a consensus "Hold" rating from analysts and an average price target of $138.38.

8. Juni 2026, 20:06 UTC

News

Illumina Inc launched the StrataMap Spatial Solution, yet shares are declining amid broader market sentiment and sector challenges.

5. Juni 2026, 23:16 UTC

Correlated Moves

Illumina Inc shares are roughly flat in after-market trading, reflecting broader market dynamics amid a slight decline in the Russell 2000 Index.

4. Juni 2026, 19:51 UTC

Illumina Inc shares are lower today, breaking a trend of higher closes since Wednesday. No specific news was identified to explain this decline.

3. Juni 2026, 23:03 UTC

Illumina Inc shares are higher in after-market trading, maintaining levels above its 20-day moving average amid broader market concerns about inflation and geopolitical tensions.

2. Juni 2026, 23:21 UTC

Correlated Moves

Illumina Inc shares declined in after-market trading, reflecting broader market trends amid mixed economic signals and a stronger-than-expected JOLTS job openings report.

1. Juni 2026, 23:46 UTC

Illumina Inc shares are higher in after-market trading following a report showing U.S. manufacturing activity expanded for the fifth consecutive month.

29. Mai 2026, 20:03 UTC

Illumina Inc is higher in Friday's session, maintaining gains since Thursday's close. No specific news was identified to explain the price action.

28. Mai 2026, 23:26 UTC

Illumina Inc shares are higher in after-market hours, reflecting routine trading activity. No specific news has been identified to explain the movement.

27. Mai 2026, 20:02 UTC

Illumina Inc is trading higher, maintaining strong momentum and peaking during Wednesday's session, despite no specific company news identified for the movement.

21. Mai 2026, 19:42 UTC

Illumina Inc's shares are higher during Thursday's session, recovering from an earlier dip and trading near the upper end of their one-month range.

20. Mai 2026, 19:56 UTC

News

Illumina Inc's stock is lower after Yahoo Finance's analysis cites weak revenue growth and concerns over its business quality. Shares rebounded earlier in the session.

19. Mai 2026, 20:03 UTC

Illumina Inc's shares are higher, supported by gains in the Life Sciences Tools & Services sub-sector, despite midday fluctuations.

18. Mai 2026, 19:15 UTC

Correlated Moves

Illumina Inc shares are lower, continuing a four-session decline amid rising Treasury yields and broader market trends, including a drop in the Russell 2000 Index.

15. Mai 2026, 23:56 UTC

Illumina Inc shares are lower in after-market hours, following a decline during the session amid broader market volatility and rising initial jobless claims.

14. Mai 2026, 23:26 UTC

News

RBC Capital initiated coverage on Illumina Inc with an Outperform rating and a $170 price target. Shares are higher in after-market trading.

13. Mai 2026, 23:21 UTC

Illumina Inc's shares are higher in after-market trading, maintaining strength above its 20-day moving average and near the top of its one-month range.

12. Mai 2026, 23:16 UTC

Correlated Moves

Illumina Inc shares are lower in after-market trading, reflecting broader market sentiment amid rising U.S. consumer prices and inflation concerns.

11. Mai 2026, 23:31 UTC

Illumina Inc shows notable after-hours gains following a recent dip. The stock remains significantly above its 20-day moving average, reflecting strong performance.

8. Mai 2026, 23:02 UTC

Correlated Moves

Illumina Inc shares fell in after-hours trading, reflecting market concerns. Despite tech strength, including Nasdaq gains, Illumina's performance lagged behind.

7. Mai 2026, 23:01 UTC

Correlated Moves

Illumina Inc declines in after-hours trading, reversing earlier gains. This drop coincides with a slight dip in high-yield corporate bonds, reflecting broader market sentiment.

6. Mai 2026, 19:06 UTC

Correlated Moves

Illumina Inc is trading higher today amid positive market sentiment. The rise in convertible and high-yield bond ETFs suggests a supportive environment for equities.

5. Mai 2026, 19:56 UTC

Correlated Moves

Illumina Inc is trading lower today, influenced by declines in the ARK Genomic Revolution ETF. Despite this, the stock remains above its 20-day moving average.

4. Mai 2026, 19:36 UTC

News

Illumina Inc reports strong Q1 2026 results, with revenue at $1.09 billion, exceeding expectations. Shares are trading higher, reflecting positive market sentiment.

1. Mai 2026, 20:02 UTC

News
Social Media

Illumina Inc reports strong Q1 results, beating EPS and revenue estimates. The company raises fiscal year 2026 guidance and announces a $1.5 billion stock buyback.

30. Apr. 2026, 14:02 UTC

Correlated Moves

Illumina Inc is trading higher, reflecting a notable uptick. This rise coincides with a 1.23% increase in the Dow Jones Index, suggesting market influence.

29. Apr. 2026, 18:12 UTC

Correlated Moves

Illumina Inc is trading significantly lower today, reflecting broader market sentiment. This decline positions it below its 20-day moving average, indicating challenging performance.

Peer-Vergleich

Kursveränderung

Illumina Inc Prognose

Kursziel

By TipRanks

-9.37% Nachteil

12-Monats-Prognose

Durchschnitt 147.25 USD  -9.37%

Hoch 185 USD

Tief 95 USD

Basierend auf 12 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Illumina Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

12 ratings

7

Buy

2

Halten

3

Sell

Stimmung

By Acuity

262 / 344 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Illumina Inc

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.
help-icon Live chat